There has been some selling insider activity on Argan, Inc. Common Stock (NYSE:AGX) recently. Director Cynthia Flanders sold 10,000 shares at an average price of $57.24 on Mon the 26th. Flanders now owns $686,880 of stock per an SEC filing yesterday. Henry A. Crumpton, Director sold $1,147,800 worth of shares at an average price of $57.39 on Mon the 26th. That brings Crumpton’s holdings to $1,147,800 as recorded in a recent Form 4 SEC filing.
Yesterday Director James W. Quinn disclosed the sale of 10,000 shares of AGX stock. The shares were sold on September 23rd for an average price of $57.08. The Director now owns $4,541,856 of the stock according to the SEC filing.
Here are some other firms who have updated their holdings. As of quarter end Royal Bank Of Canada had sold a total of 300 shares trimming its position 13.0%. The value of the investment in Argan, Inc. Common Stock increased from $81,000 to $83,000 a change of $2,000 since the last quarter. Hawk Ridge Capital Management Lp expanded its position by buying 23,822 shares an increase of 8.1% as of 06/30/2016. Hawk Ridge Capital Management Lp now controls 319,573 shares valued at $13,333,000. The total value of its holdings increased 28.2%.
Qs Investors, LLC divested its ownership by shedding 16,400 shares a decrease of 6.3%. Qs Investors, LLC controls 244,232 shares worth $10,189,000. The value of the position overall is up by 11.2%. As of the end of the quarter Two Sigma Investments, Lp had acquired 118,385 shares growing its holdings by 1,292.6%. The value of the investment in (AGX) went from $322,000 to $5,321,000 a change of 1,552.5% for the reporting period.
Singular Research added AGX to its research portfolio giving it an initial rating of “Buy” and price target of $41.00. Equity analyst Avondale Partners downgraded the stock and raised the price target on September 15 boosting the price target from $36.00 to $39.00 and cutting the rating from “Market Outperform” to “Market Perform”.
On September 15 the stock rating was downgraded to “Market Perform” from “Market Outperform” and a price target of $39.00 was set by Avondale Partners.
The company is up since yesterday’s close of $57.31. It is currently trading at $58.00 marginally over $50.45, the stock’s 50 day moving average and a tad above the 200 day moving average of $41.15. The 50 day moving average was up $7.55 or +14.97% whereas the 200 day average was up by +40.95%.
The company’s P/E ratio is 17.82 and the market cap of the company is 871.86M. As of the last earnings report the EPS was $3.26 and is projected to be $3.62 for the current year with 15,032,000 shares currently outstanding. Analysts expect next quarter’s EPS to be $0.75 and the next full year EPS is anticipated to be $3.69.